46.98USD+1.73%Mkt Cap: 8.39B USDP/E: —Last update: 2026-05-26
Tempus AI, Inc. operates as a healthcare technology company in the United States. It offers the Tempus platform, a closed-loop, full-stack, bi-directional integrations between a clinician's desktop and its laboratory dia…
Industry Peers
Health Information Services25.85BUSDP/E 29.1
11.66BUSDP/E 78.1
7.43BSEKP/E 33.1
7.35BUSDP/E 35.7
5.05BTRYP/E 27.0
4.13BUSD—
3.79BUSDP/E 29.5
3.16BUSD—
Indicators:|
Key Statistics
Company
Market Cap8.39B USD
Enterprise Value9.03B USD
Revenue (TTM)1.36B USD
Gross Profit797.90M USD
Net Income (TTM)-245.03M USD
Revenue/Share7.735 USD
Last Price46.98 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees3.8K
CountryUS
SectorHealthcare
IndustryHealth Information Services
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-338.11
PEG—
EV/EBITDA-48.73
EV/Revenue6.62
P/S6.12
P/B16.85
EPS (TTM)-1.72
EPS (Forward)-0.14
52W Range
41.738% of range104.32
52W High104.32 USD
52W Low41.73 USD
Profitability
Gross Margin62.74%
Oper. Margin-24.33%
EBITDA Margin-13.58%
Profit Margin-19.27%
ROE-49.87%
ROA-10.77%
Growth
Revenue Growth36.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF-218.09M USD
CapEx (TTM)27.27M USD
FCF Margin-4.09%
FCF Yield-0.66%
Net Debt679.46M USD
Net Debt/EBITDA-3.67
Balance Sheet
Debt/Equity2.70
Current Ratio3.31
Quick Ratio2.99
Book Value/Sh2.759 USD
Cash/Share3.559 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating2.1 (Buy)
Target (Mean)67.20 USD
Target Range35.00 USD – 100.00 USD
# Analysts15
Ownership
Shares Out.174.52M
Float113.93M
Insiders37.14%
Institutions56.63%
Short Interest
Short Ratio5.0d
Short % Float27.03%
Short % Out.14.91%
Shares Short26.76M
Short (prev mo.)27.63M
Technical
SMA 5049.23 (-4.6%)
SMA 20066.34 (-29.2%)
Beta—
S&P 52W Chg28.31%
Avg Vol (30d)6.10M
Avg Vol (10d)6.42M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—